Increasing evidence suggests that cancer patients have an elevated risk of COVID-19 infections and higher mortality rates. The COVID-19 pandemic has accelerated technology adoption in many different industry sectors and the healthcare industry is no different. Digital health and advanced cancer diagnostics play a pivotal role by guiding precision medicine and facilitating patient care in the comfort of the patients’ homes.
Join an exclusive webinar hosted by APACMed where we will hear from mClinica Pharmacy Solutions’ CEO and Founder, Farouk Meralli, and three other panelists on how digital health startups are advancing cancer care in the e-patient era.
Farouk will address how mClinica Pharmacy Solutions has developed a compliant digital Oncology Patient Assistance Program that reduces administrative burden, improves hospital pharmacy efficiencies, and also improves the patient’s access and affordability of medication. This session will be extremely insightful for oncology-specific pharmaceutical companies wanting to switch from a traditional pen-and-paper Patient Assistance Program to a digital solution to drive better healthcare outcomes.
SwipeRx is proud to share the impact we have made throughout the year with the release of the SwipeRx Annual Impact Report, developed in collaboration
Previous image Next image In recognition of World Antimicrobial Awareness Week 2024 earlier this month, SwipeRx reaffirms its commitment to improving pharmacy professionals’ capacity and
At SwipeRx, we are proud to have participated in several Pharmacist Summits and Conferences across the Philippines, reaffirming our dedication to empowering pharmacy professionals with
© 2024 mClinica Pte. Ltd. All Rights Reserved.